Pandiella, Atanasio

Network Lab View Statistics Email Alert RSS Feed

Perfil

Profile

Firma en Digital.CSIC (*):

Pandiella, Atanasio

Otras firmas:

Pandiella-Alonso, Atanasio

Centro o Instituto:

CSIC-USAL - Instituto de Biología Molecular y Celular del Cancer de Salamanca (IBMCC)

Departamento:

Laboratorio 15: Role of soluble factors and membrane receptors in processes of proliferation, differentiation and oncogenic transformation. Grupo: Signalling by receptor tyrosine kinases

Categoría Profesional:

Investigador Científico

Especialización:

Kinases in oncology

Email:

atanasio@usal.es

ORCID:

0000-0002-4704-8971

Perfil en Google Scholar:

My Google Scholar Citations

Página web:

Personal Website

Otros identificadores (con url):

Scopus Author ID
ResearcherID

Publications (Articles)

Results 1-20 of 146 (Search time: 0.001 seconds).

	Rights	Issue Date	Title	Author(s)	Type
1	closedAccess	2013	A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers	Morancho, B.; Pandiella, Atanasio ; Arribas, Joaquín	artículo
2	closedAccess	2011	A modular approach to trim cellular targets in anticancer drug discovery	Ríos-Luci, Carla; Díaz-Rodríguez, Elena ; Pandiella, Atanasio	artículo
3	openAccess	18-Dec-2019	A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors	Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena ; Pandiella, Atanasio ; Győrffy, Balázs; Ocaña, Alberto	artículo
4	closedAccess	2005	Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin	Yuste, Laura; Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Pandiella, Atanasio	artículo
5	openAccess	2014	Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis	Ocaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio ; Amir, Eitan	artículo
6	closedAccess	2012	Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer	Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Re-Louhau, M. F. ; Seoane, Samuel ; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio	artículo
7	openAccess	30-Aug-2019	Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer	Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Pandiella, Atanasio ; Galán-Moya, Eva María; Ocaña, Alberto	artículo
8	closedAccess	2020	Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms	Ríos-Luci, Carla; Díaz-Rodríguez, Elena ; Gandullo-Sánchez, Lucía; Díaz-Gil, Laura; Ocaña, Alberto; Pandiella, Atanasio	artículo
9	openAccess	Oct-2020	Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine	Fuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio ; Ocaña, Alberto	artículo de revisión
10	openAccess	2020	An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy	Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio ; Ocaña, Alberto; Alonso-Moreno, Carlos	artículo
11	openAccess	2012	Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands	Carrión-Salip, Dolors; Pandiella, Atanasio ; Massaguer, Anna	artículo
12	openAccess	21-Aug-2020	Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment	Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio ; Ocaña, Alberto; Alonso, Carlos	artículo
13	closedAccess	2016	Antiproliferative effect of Synadenium grantii Hook f. stems (Euphorbiaceae) and a rare phorbol diterpene ester	Campos, Adriana; Barbosa Vendramini-Costa, Débora; Barbarini Longato, Giovanna; Tailyn Zermiani, Ana; Tasca Gois Ruiz, Lúcia; Carvalho, João Ernesto de; Pandiella, Atanasio ; Cechinel Filho, Valdir	artículo
14	openAccess	2015	Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer	Cuenca-López, María D.; Serrano-Heras, Gemma ; Montero, Juan Carlos ; Morales, Jorge C.; Pandiella, Atanasio ; Ocaña, Alberto	artículo
15	openAccess	2015	Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2	Pandiella, Atanasio ; Morís, Francisco; Ocaña, Alberto; Núñez, Luz-Elena; Montero, Juan Carlos	artículo
16	openAccess	2017	Antitumoral effect of Ocoxin in hepatocellular carcinoma	Díaz-Rodríguez, Elena ; El-Mallah, Al-Mahy; Sanz, Eduardo; Pandiella, Atanasio	artículo
17	openAccess	2016	Antitumoral effect of Ocoxin on acute myeloid leukemia	Díaz-Rodríguez, Elena ; Hernández-García, Susana; Sanz, Eduardo; Pandiella, Atanasio	artículo
18	openAccess	2018	Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer	Díaz-Rodríguez, Elena ; Sanz, Eduardo; Pandiella, Atanasio	artículo
19	closedAccess	2008	Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo	Mitsiades, C. S.; Ocio, Enrique M. ; Pandiella, Atanasio ; Maiso, Patricia; Gajate, Consuelo ; Garayoa, Mercedes ; Vilanova, David; Montero, Juan Carlos ; Mollinedo, Faustino ; San Miguel, Jesús F.	artículo
20	closedAccess	1996	Autocrine regulation of membrane transforming growth factor-α cleavage	Pandiella, Atanasio	artículo